EG16042A - Improvement in or relating to derivatives of a-21978 c cyclic peptides and their production - Google Patents

Improvement in or relating to derivatives of a-21978 c cyclic peptides and their production

Info

Publication number
EG16042A
EG16042A EG296/83A EG29683A EG16042A EG 16042 A EG16042 A EG 16042A EG 296/83 A EG296/83 A EG 296/83A EG 29683 A EG29683 A EG 29683A EG 16042 A EG16042 A EG 16042A
Authority
EG
Egypt
Prior art keywords
relating
derivatives
improvement
production
cyclic peptides
Prior art date
Application number
EG296/83A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of EG16042A publication Critical patent/EG16042A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62Streptosporangium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG296/83A 1982-05-21 1983-05-18 Improvement in or relating to derivatives of a-21978 c cyclic peptides and their production EG16042A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/380,498 US4399067A (en) 1982-05-21 1982-05-21 Derivatives of A-21978C cyclic peptides

Publications (1)

Publication Number Publication Date
EG16042A true EG16042A (en) 1986-12-30

Family

ID=23501401

Family Applications (1)

Application Number Title Priority Date Filing Date
EG296/83A EG16042A (en) 1982-05-21 1983-05-18 Improvement in or relating to derivatives of a-21978 c cyclic peptides and their production

Country Status (15)

Country Link
US (1) US4399067A (ro)
KR (1) KR860002185B1 (ro)
AT (1) AT380022B (ro)
CA (1) CA1215043A (ro)
DD (1) DD209810A5 (ro)
DK (1) DK220983A (ro)
EG (1) EG16042A (ro)
ES (1) ES8407012A1 (ro)
FI (1) FI831746L (ro)
GR (1) GR79259B (ro)
HU (1) HU192955B (ro)
PH (1) PH21382A (ro)
PL (1) PL242096A1 (ro)
PT (1) PT76701B (ro)
RO (1) RO86721B (ro)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA883887B (en) * 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US5256548A (en) * 1990-11-21 1993-10-26 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
US5140101A (en) * 1990-11-21 1992-08-18 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
CA2393907A1 (en) 1999-12-15 2001-06-21 Cubist Pharmaceuticals Inc. Novel lipopeptides as antibacterial agents
KR20020063228A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
US6794490B2 (en) * 1999-12-15 2004-09-21 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
EP1423137B1 (en) * 2001-08-06 2009-04-29 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
ES2442167T3 (es) * 2008-12-22 2014-02-10 Cubist Pharmaceuticals, Inc. Nuevos agentes antibacterianos para el tratamiento de infecciones gram positivas
US8343912B2 (en) * 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150059A (en) * 1962-12-26 1964-09-22 Lilly Co Eli Penicillin deacylation via actinoplanaceae fermentation
US4208403A (en) * 1978-10-16 1980-06-17 Eli Lilly And Company A-21978 Antibiotics and process for their production
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4289692A (en) * 1979-12-13 1981-09-15 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus

Also Published As

Publication number Publication date
PH21382A (en) 1987-10-15
AT380022B (de) 1986-03-25
RO86721A (ro) 1985-04-17
CA1215043A (en) 1986-12-09
GR79259B (ro) 1984-10-22
US4399067A (en) 1983-08-16
FI831746A0 (fi) 1983-05-18
KR860002185B1 (ko) 1986-12-24
HU192955B (en) 1987-08-28
PT76701A (en) 1983-06-01
DD209810A5 (de) 1984-05-23
ES522561A0 (es) 1984-09-01
ATA178383A (de) 1985-08-15
ES8407012A1 (es) 1984-09-01
KR840005076A (ko) 1984-11-03
PL242096A1 (en) 1984-07-02
PT76701B (en) 1986-03-27
RO86721B (ro) 1985-05-01
DK220983A (da) 1983-11-22
DK220983D0 (da) 1983-05-18
FI831746L (fi) 1983-11-22

Similar Documents

Publication Publication Date Title
GB8812993D0 (en) Improvements in/relating to production of protein products
GB2176584B (en) Improvements relating to the treatment of tobacco
GB2169444B (en) Improvements in or relating to methods of making semiconductor devices
EG16042A (en) Improvement in or relating to derivatives of a-21978 c cyclic peptides and their production
EP0227159A3 (en) Improvements in and relating to the production of beer
GB8814080D0 (en) Improvements in/relating to manufacture of lollipops
IL68700A0 (en) Improvements relating to a-21978c cyclic peptide derivatives and their production
DE3573911D1 (en) Improvements in and relating to the production of transfers
GB2184088B (en) Improvements relating to the production of tea and the like bags
GB2188107B (en) Improvements in and relating to gasket manufacture
PH23417A (en) Improvement in or relating to derivatives of a-21978c cyclic peptide
HK27890A (en) Improvements relating to the treatment of particulate material
DE3471463D1 (en) Improvements in or relating to containers and methods of manufacturing containers
DE3363813D1 (en) Improvements in and relating to substituted tetrahydrona phthalenes
GB2186579B (en) Improvements relating to the radio-labelling of proteins
PT67054A (en) Improvements in or relating to beams and methods of making them
GB2133056B (en) Improvements in and/or relating to cribwalling
GB2121402B (en) N-methanesulfonic acid derivatives of 3-0-demethylistamycin b and production thereof
EG16043A (en) Improvements in or relating to a-21987 cyclic peptide derivatives and their production
GB2185244B (en) Improvements in and relating to pilfer-proof rings
EG16044A (en) Improvements in or relating to derivatives of a-21978 cyclic peptides
IL73001A0 (en) Improvements in and relating to 6-oxodecahydroquinolines
GB2123744B (en) Improvements in and relating to the moulding of materials
GB8314853D0 (en) Production and immobillisation of modified proteins
IL69611A0 (en) Preparation of 1-substituted cyclic lactam-2-carboxylic acids and their derivatives